Our Heritage is In Hematology
European Hematology Association Annual Congress 2020
For 10 years, we have pioneered the science behind IDH mutations in hematologic malignancies and PKR activation in rare hemolytic anemias.
Promise of IDH
Find out more about IDH mutations in hematologic malignancies and solid tumors.
is at our Core
in Rare Hemolytic
Know PK Deficiency